We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,335.00 | 1,333.50 | 1,334.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.22 | 55.34B |
Date | Subject | Author | Discuss |
---|---|---|---|
11/5/2021 12:58 | Back in the day GSK often traded higher on days like this, monty you probably remember. Acts differently these days. | essentialinvestor | |
11/5/2021 12:56 | euro Should have waited until 1265p, this going lower. Elliott who has not said a word, even if they have stake can't keep get this shareprice higher, when next month we will know about dividend policy, on the split. | montyhedge | |
11/5/2021 12:52 | just got back in, and find my order at 1320 has been filled. | eurofox | |
11/5/2021 12:41 | I hope so for your sake at least. | abdullla | |
11/5/2021 12:12 | Of course, that's already known. How the split comes and what it would be worth is the current unknown. Rest assured, it will be worth a lot more than GSK's share price today. | tradermichael | |
11/5/2021 12:03 | Whatever happens dividends will be cut when split comes, from 80p to 55p seems to be the forecast, from Credit Suisse. | montyhedge | |
11/5/2021 11:46 | He's serious with his stake ..... how many rounds do y'all think Emma would survive once the fight started? | tradermichael | |
11/5/2021 11:40 | Paul Elliott Singer is an American hedge fund manager, activist investor, philanthropist, and the founder, president and Co-CEO of Elliott Management. Fortune magazine described Singer as one of the "smartest and toughest money managers" in the hedge fund industry. | tradermichael | |
11/5/2021 11:22 | When do they ever operate with a large stake? You need to get on to Paul Singer, the billionaire owner of Elliot, and explain that he's got his business model all wrong. I'm sure he'd appreciate it. | alex1621 | |
11/5/2021 11:20 | Would it be impossible for them to work with a predator? | alphorn | |
11/5/2021 10:48 | I bet they sell their cfds in GSK they can't do anything with a tiny stake. | montyhedge | |
11/5/2021 10:04 | Bizarre, this should have been defensive today, and before anyone quotes sterling its at 1.41 and has lost value against the dollar and euro every year for 11 years altho its lost more against the euro, so sterling is a weak and getting weaker currency ( productivity in the U.K. at Victorian levels so gov has to trash currency to stay competitive ) U.K. will be like Argentina soon haha. Cant wait to see Elliot’ plan for gsk break up and sell off, its the only way this pile of steaming will get a return for shareholders now. | porsche1945 | |
11/5/2021 08:42 | They would have to work with others ... maybe that's why they are in meetings this week? | alex1621 | |
11/5/2021 08:35 | Elliott with a undeclared stake can't influence anything. | montyhedge | |
10/5/2021 12:51 | Covid was just the start. Next we'll make a vaccine for cancer.... Wouldn't it be better, he says, if Covid vaccines worked not by identifying what makes variants different but against what they have in common. He's doing just that. "We're making a vaccine that will protect against every variant that's ever been produced and should protect against all possible variants that appear in the future."It's a bold claim. But Weissman isn't finished there. "We've had three coronavirus epidemics in 20 years [Sars, Mers and Covid]. It would be foolish to think we're not going to have more. So we've also been working on our pan-coronavirus vaccine."... Daily Telegraph | xxxxxy | |
10/5/2021 12:40 | Why waiving intellectual property rights for Covid vaccines is wrongA zero IP world would discourage companies from investing in new vaccines when the next pandemic comesPHILIP STEVENS9 May 2021 7:00pm.... Daily Telegraph | xxxxxy | |
10/5/2021 06:38 | Happy to add to holding at about 12.50 ish. But that price increasingly unlikely.Bore da. | xxxxxy | |
10/5/2021 06:36 | Scipio Britannicus9 May 2021 11:37PMThe UK must now have a priority programme to bring the manufacture of essential supplies and services back home. Covid has proved that relying on foreign suppliers, particularly from the EU, is risking the safety and security of the country, and it isn't just vaccines where bans have recently been implemented or threatened, it's PPE, ventilators and even power supplies.... Daily Telegraph | xxxxxy | |
10/5/2021 06:30 | So referring to previous, things about GSK are not so simple anymore. It is an imperative industry for the UK health security. | xxxxxy | |
10/5/2021 06:28 | Export barriers threaten global Covid battleThe US, European Union and India all face heavy domestic pressure to stop vaccines made in their countries from being sent abroadByLouis Ashworth9 May 2021 7:45pmThe world's fight against Covid-19 is under threat as countries push up export barriers amid fears that vaccine nationalism could haunt the global trade system for months to come..... Daily Telegraph | xxxxxy | |
09/5/2021 14:58 | I will buy that when the share price goes back up! | abdullla | |
09/5/2021 12:57 | Says nothing about Elliot's interest being "fake news"? Quite the contrary. | alex1621 | |
09/5/2021 10:43 | Sunday Times, two page article on GlaxoSmithKline. Not worth buying as it is regurgitating same old. One point of note , article suggests shares were bought through derivatives | whatsup32 | |
09/5/2021 10:39 | https://www.theguard | abdullla | |
08/5/2021 18:33 | I know some one will not like Mondays. And need to get a Taxi . Your Fiered | notbitcoin |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions